Literature DB >> 23233582

Thrombosis in pregnancy: updates in diagnosis and management.

Ian A Greer1.   

Abstract

Acute venous thromboembolism poses significant problems in pregnancy, a time when objective diagnosis and prompt treatment are essential. Events can occur at any stage in pregnancy, but the period of greatest risk is in the weeks after delivery. Ultrasound venography remains the diagnostic technique of choice for deep venous thrombosis. For pulmonary thromboembolism, ventilation perfusion lung scan is usually preferred more than computerized tomography pulmonary angiography because of the lower maternal radiation dose and the lower prevalence of coexisting pulmonary problems. Low-molecular-weight heparin is the agent of choice for treatment of venous thromboembolism in pregnancy, and treatment should be provided for a minimum of 3 months and for at least 6 weeks after delivery. New anticoagulant agents such as dabigatran, rivaroxaban, or apixaban are not recommended for use in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233582     DOI: 10.1182/asheducation-2012.1.203

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  17 in total

Review 1.  Hematologic complications of pregnancy.

Authors:  Danielle M Townsley
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

Review 2.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

3.  Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.

Authors:  M Hoeltzenbein; E Beck; K Meixner; C Schaefer; R Kreutz
Journal:  Clin Res Cardiol       Date:  2015-07-21       Impact factor: 5.460

4.  Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.

Authors:  Philippa Middleton; Emily Shepherd; Judith C Gomersall
Journal:  Cochrane Database Syst Rev       Date:  2021-03-29

5.  Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience.

Authors:  L Coriu; R Ungureanu; R Talmaci; V Uscatescu; M Cirstoiu; D Coriu; E Copaciu
Journal:  J Med Life       Date:  2014 Oct-Dec

Review 6.  Do pregnant women have a higher risk for venous thromboembolism following air travel?

Authors:  Morteza Izadi; Mohammad Javad Alemzadeh-Ansari; Davood Kazemisaleh; Maryam Moshkani-Farahani; Akbar Shafiee
Journal:  Adv Biomed Res       Date:  2015-02-23

Review 7.  Venous thromboembolism in women: new challenges for an old disease.

Authors:  André Luiz Malavasi Longo de Oliveira; Adilson Ferraz Paschôa; Marcos Arêas Marques
Journal:  J Vasc Bras       Date:  2020-07-06

8.  Application of the RCOG Risk Assessment Model for Evaluating Postpartum Venous Thromboembolism in Chinese Women: A Case-Control Study.

Authors:  Ying-Zhou Ge; Chen Zhang; Yan-Qing Cai; He-Feng Huang
Journal:  Med Sci Monit       Date:  2021-07-07

Review 9.  The new factor Xa inhibitor: Apixaban.

Authors:  Sangeeta Bhanwra; Kaza Ahluwalia
Journal:  J Pharmacol Pharmacother       Date:  2014-01

Review 10.  Pulmonary thrombo-embolism in pregnancy: diagnosis and management.

Authors:  Louise E Simcox; Laura Ormesher; Clare Tower; Ian A Greer
Journal:  Breathe (Sheff)       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.